Outsourced R&D services for drug, biologic, and device developers. Common offerings: clinical trial site management and monitoring, preclinical toxicology, bioanalytical method validation, central laboratory testing, regulatory affairs and submissions, pharmacovigilance, biometrics, post-market surveillance, and translational research. Some CROs are full-service (Phase I through IV); others specialize in a niche.

What is the difference between a CRO and a CDMO?

A CRO runs RESEARCH services for other companies (clinical trials, preclinical, data work). A CDMO runs MANUFACTURING services for other companies (drug substance, drug product, fill-finish). They sit on different parts of the drug development chain. Some integrated providers offer both ("CDRMO" or full-stack), but most specialize in one or the other.

Which European countries have the strongest CRO presence?

Poland leads on cost-competitive clinical operations (Selvita, Pharmacy Healthcare, plus the major CRO sites). Germany has deep clinical trial infrastructure (ICON, Charles River, IQVIA). The Baltics carry specialty preclinical and bioanalytical CROs. Switzerland and the Nordics host higher-tier specialty operators.

How are CROs verified in this directory?

Every profile is hand-reviewed: leadership confirmed by primary source, physical site address sourced from official disclosures, capability and certification claims (GLP, GCP, ISO 9001, ISO 13485 where relevant) backed by documents, and a registry note explaining service scope.

European CRO Companies & Services

Vilnius translational and precision-medicine CRO offering human biospecimen procurement, preclinical study design, custom animal models, and bioanalytical laboratory services for Northeastern Europe.

Lead: Olga PotapovaFounder and Chief Executive Officer, Cureline Group
Scale: CRO service delivery

Umea preclinical CRO built around the proprietary NIF mouse model, supplying in vivo efficacy readouts for anti-fibrotic and anti-inflammatory drug candidates across liver and kidney programs.

Lead: Sofia MayansCo-Founder and Chief Executive Officer
Scale: Preclinical contract research

Riga-based pharmaceutical and biotech consultancy covering regulatory affairs, pharmacovigilance, GMP and GDP compliance, and eCTD publishing across the EU and CIS, with a proprietary Prudenta literature-monitoring stack.

Lead: Polina DombureFounder and Chief Executive Officer
Scale: Regulatory consulting service delivery across EU and CIS

Kuopio full-service CRO owned by WDB Holdings (Japan), covering Phase I-IV clinical trials, bioanalytics, regulatory affairs, pharmacovigilance, and medical device and food studies across the EU and Japan.

Lead: Tuija KeinonenChief Executive Officer
Scale: Full-service CRO operations

Kuopio neuroscience-focused discovery center within Charles River, offering in vitro and in vivo pharmacology, imaging, behavioral testing, and biomarker analysis from Finland.

Lead: James C. FosterChairman, President and CEO
Scale: Discovery-services platform

Horsholm preclinical CRO and biotech platform providing obesity, metabolic-disease, peptide, and drug-discovery services and programs.

Lead: Henrik BlouCEO
Scale: Commercial preclinical CRO platform

Oulu CRO providing ADME-Tox, DMPK, bioanalysis, and drug-discovery support services for preclinical and translational development programs.

Lead: Outi KontkanenCEO
Scale: Commercial CRO service platform

Vilnius pharmaceutical-development and testing platform combining formulation development, analytical services, quality control, and market-access support for complex European programs.

Lead: Edita Griniute-MistinieneFounder and Chief Executive Officer
Scale: Pharmaceutical development and quality-control platform

German clinical-development node linking Baltic and Polish programs to EU trial execution, safety surveillance, and regulatory delivery.

Lead: August J. TroendleFounder, Chairman and Chief Executive Officer
Scale: European clinical-services delivery

Kaunas-headquartered integrated pharmaceutical-services platform spanning clinical trials, pharmacovigilance, regulatory affairs, and medical information.

Lead: Xavier DuburcqChief Executive Officer
Scale: Pan-European clinical-services network

Frankfurt clinical-research operations node anchoring ICON's German delivery surface across monitoring, trial management, and sponsor support.

Lead: Barry BalfeChief Executive Officer
Scale: Global CRO network with Germany execution node

Warsaw clinical-research operations node connecting full-service CRO execution, trial management, and country-level delivery capacity in Poland.

Lead: Barry BalfeChief Executive Officer
Scale: Global CRO network with Poland execution node

Warsaw clinical-development and project-delivery node connecting Medpace's global CRO model into the Polish trial ecosystem.

Lead: August J. TroendleChief Executive Officer and Chairman
Scale: Global CRO network with Poland office node

Warsaw-centered research-site network node linking Polish investigator access, hybrid studies, and decentralized clinical-trial delivery.

Lead: Łukasz BęczkowskiChief Operating Officer
Scale: Multi-country site-network platform

CRO companies in Europe — biotech directory

Where does this category cluster most clearly?

Which standards and public evidence are already visible?

Why this category matters

CRO by country

Best CRO Companies in Europe (2026)

Other categories

CRO records

Cureline Baltic

InfiCure Bio

Inpharmatis

Oy Medfiles Ltd.

Charles River Laboratories Finland

Gubra

Admescope

Profarma

Medpace Germany

Biomapas

ICON Germany

ICON Poland

Medpace Poland

Pratia Poland

Frequently asked questions

Read the category, then move into cities and countries.